GSK plcGSKNYSE
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank13
Year-over-Year Change
Year-over-year operating income growth rate
Percentile
P13
Within normal range
vs 3Y Ago
-1.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -63.27% |
| Q4 2025 | 28.18% |
| Q2 2025 | -8.71% |
| Q1 2025 | 218.39% |
| Q4 2024 | 268.25% |
| Q3 2024 | -88.52% |
| Q2 2024 | 10.47% |
| Q1 2024 | 160.03% |
| Q4 2023 | -70.60% |
| Q3 2023 | -8.97% |
| Q2 2023 | 2.83% |
| Q1 2023 | 11.46% |
| Q4 2022 | 56.84% |
| Q3 2022 | 10.18% |
| Q2 2022 | -52.86% |
| Q1 2022 | 156.20% |
| Q4 2021 | -35.14% |
| Q3 2021 | 8.24% |
| Q2 2021 | -24.69% |
| Q1 2021 | 59.57% |
| Q4 2020 | -42.90% |
| Q3 2020 | -34.81% |
| Q2 2020 | 41.51% |
| Q1 2020 | 5.89% |
| Q4 2019 | -11.41% |
| Q3 2019 | 44.68% |
| Q2 2019 | 3.92% |
| Q1 2019 | -8.11% |
| Q4 2018 | -18.64% |
| Q3 2018 | 145.19% |
| Q2 2018 | -37.18% |
| Q1 2018 | 142.19% |
| Q4 2017 | -72.72% |
| Q3 2017 | 9485.00% |
| Q2 2017 | -101.16% |
| Q1 2017 | 188.74% |
| Q4 2016 | -58.42% |
| Q3 2016 | 1047.68% |
| Q2 2016 | -120.89% |
| Q1 2016 | 384.65% |